No Picture
News

Shareholder Alert: Robbins LLP Announces It Is Investigating Innate Pharma S.A. (IPHA) for Misleading Shareholders

SAN DIEGO and MARSEILLE, France, Oct. 27, 2020 /PRNewswire/ — Shareholder rights law firm Robbins LLP announces it is investigating whether certain officers and directors of Innate Pharma S.A. (NASDAQ: IPHA) violated federal securities laws. Innate… […]

No Picture
News

Biocept Executes In-Network Provider Agreement with Health Net Federal Services Extending Coverage for its Liquid Biopsy Oncology Platform to the TRICARE West Region Network

SAN DIEGO, Sept. 8, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes, announces it has entere… […]

No Picture
News

Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia

Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization

SAN DIEGO and ADELAIDE, Australia, Sept. 1, 2020 /PRNewswire/ — The Bridgewest Group, a premier private investment company that focuses on disrupt… […]

No Picture
News

Apricorn’s Aegis Secure Key 3NX USB 3.2 Flash Key Receives FIPS 140-2 Level 3 Validation

Apricorn’s 4th Generation Flash Key is awarded NIST’s highest level of FIPS validation granted to portable data storage devices.

POWAY, Calif., Aug. 27, 2020 /PRNewswire/ — Apricorn, the leading manufacturer of software-free, 256-bit AES XTS hardwar… […]

No Picture
News

ImmunoScape Targets Immunology Breakthroughs for COVID-19 and Oncology with $11M in Global Financing Led by Anzu Partners and UTEC

The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines

SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]

No Picture
News

Qualigen Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CARLSBAD, Calif., Aug. 2, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $1… […]

No Picture
News

Viking Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH; New Data from 12-Week Phase 2 Trial to be Highlighted at EASL- IND Filed for VK0214 in X-ALD; Phase 1 Trial Expected to Begin Q3 2020- Ba… […]